Carbohydrate-deficient transferrin (CDT) is reported to be an accurate biomarker for the detection of chronic alcohol abuse and for monitoring abstinence [1, 2] . Transferrin (Tf) is the most important iron transport protein.
INTRODUCTION
.
Stibler and Kjellin [6] first reported that Tf isoforms, with an isoelectric point (pI) greater than 5.7, were present in alcoholic subjects. These Tf isoforms correspond to asialo-Tf, monosialo-Tf, and disialo-Tf and are collectively referred to as CDT [1, 2] . Sustained alcohol consumption causes a change in the glycoform pattern and an increase in CDT levels. The half-life of CDT is 1-1.5 weeks. Generally, it takes more than 2 weeks of abstinence for CDT levels to return to normal [1, 4, 7, 8] . Measurement of CDT levels has not been routinely performed over the years because traditional methods for measuring CDT levels, such as isoelectric focusing, are laborious and time-consuming. Several commercial immunoassay kits have been developed for the measurement of CDT levels, but the inclusion of trisialo-Tf in the CDT fraction can result in false high CDT values when these tests are used [2, 9, 10] . Recently, new methods, including capillary zone electrophoresis (EP) [11] , high-performance liquid chromatography (HPLC) [3, 10, 12] , and direct immunoassay using monoclonal antibodies [4] have been developed. These methods are automated and produce more reliable data.
To date, the measurement of CDT levels has not been performed routinely for monitoring chronic alcohol abuse in Korea. To our knowledge, CDT levels have rarely been measured in an Asian population. In this study, we evaluated the analytical performance of a test for measuring CDT levels by using capillary EP (Sebia, Every, France) and determined the cut-off values for CDT in a Korean population.
MATERIALS AND METHODS

Patients
To evaluate the relationship between CDT levels and alcohol consumption, we included 45 alcoholic patients who had liver disease (39 men and 6 women, age: 18-71 yr; 35, alcoholic liver disease: cirrhosis or fatty liver or pancreatitis and 10, nonalcoholic liver disease: hepatitis A or B) and 48 healthy individuals were included in the study. Among the 48 healthy individuals, 42 control subjects (22 men and 20 women, age: 25-55 yr, median age: 40 yr) were selected to validate the cut-off value.
All of the 42 individuals were either totally abstinent or consumed not more than 25 g of alcohol per day. None of the patients showed clinical and laboratory evidence of chronic alcohol abuse. To evaluate the effect of liver disease on CDT levels, 28 abstinent patients who had liver disease (13 men and 15 women, median age: 41 yr (range, 26-63 yr); 3, acute hepatitis A; 22, chronic hepatitis B; 2, chronic hepatitis C; and 1, primary biliary cirrhosis) were also enrolled. The diagnosis of liver disease was performed by determining abnormal levels of liver enzymes, serological markers such as hepatitis B virus, hepatitis C virus, and hepatitis A virus, and radiological findings. Information regarding alcohol consumption (average daily consumption of alcohol, duration of alcohol consumption, and date and dose of recent drinking) was collected during an interview. The daily intake of each beverage was expressed in grams of pure ethanol, and mean daily alcohol consumption was calculated using the frequency of drinking and daily intake of each drinking event. In order to analyze the relationship between CDT and alcohol consumption, we excluded patients who had genetic variants of the Tf isoforms. We also excluded patients who gave incomplete information regarding their alcohol habit or if the last day they had a drink before more than 2 weeks. This study was approved by the Institutional Review Board of Konkuk University Medical Center (Seoul, Korea).
Determination of CDT levels
1) Capillary electrophoresis
In a capillary zone electrophoresis system (Sebia), the 
2) Nephelometric measurement of CDT levels
We measured CDT levels using an N Latex CDT assay (Dade Behring, Marburg, Germany). This is a direct method and is based on the direct nephelometric measurement of disialo-Tf and asialo-Tf by using specific antibodies. We used a BN II nephelometer system (Dade Behring, Marburg, Germany) for this assay, with a ref- 3. Peformance of the capillary electrophoresis method for measuring CDT levels
1) Precision
Intra-run precision and total precision were determined as described in the CLSI protocol EP5-A2 using control material [13] . Each control was analyzed in duplicate over 5 days with 2 runs.
2) Comparison between the two methods
In total, 40 samples covering a wide range of CDT values were analyzed using the capillary EP and nephelometric methods. The values from the 2 methods were compared using Pearson' s correlation coefficient for regression analysis.
Statistics
Relationships between the variables were analyzed using Student' s t-test and Mann-Whitney test for continuous variables. Pearson' s correlation and Bland-Altman plots were used for the comparison studies. Agreement between the tests was assessed using the k coefficient as follows: k coefficient greater than 0.81 was con- 
RESULTS
Precision
The precision within each run had a low of 6.9% (normal control, mean value 0.51%) and high of 1.8% (abnormal control, mean value 6.96%). The total precisions of normal and abnormal control were 6.6% and 4.5%, respectively (Table 1) .
Comparison of CDT levels measured by capillary EP and those measured by nephelometry
The CDT values measured using capillary EP correlat- 
Validation of the reference interval and baseline CDT levels in abstinent individuals
None of the 42 healthy control subjects (men, 22 and women, 20) had a CDT level above the cut-off value that was provided by manufacturer (1.3%). The average CDT value for the healthy subjects was 0.52% (SD, 0.18; median, 0.5; range, 0.3-1.0). The CDT levels in men (mean, 0.57; SD, 0.19) were significantly higher than those in women (mean, 0.46; SD, 0.15; P=0.02).
Comparison of CDT and g -glutamyl transpeptidase levels in abstinent patients with liver disease and those in healthy controls
Both CDT and g -glutamyl transpeptidase (GGT) levels were significantly higher in abstinent patients with liver disease than in healthy abstinent individuals (0.9% vs.
0.5%, P value=0.046; 109.5 mg/dL vs. 28.5 mg/dL, P value <0.001, respectively) ( Table 2 , Fig. 2) . However, the difference between the 2 groups was more pronounced for the GGT values. Moreover, the positive rate of GGT, according to the cut-off, was significantly higher in the abstinent patients with liver disease than in healthy individuals (P<0.001). In contrast, the positive rate of CDT was very low in both groups (Table 2 ).
CDT levels in relation to alcohol consumption
The amount of daily alcohol intake significantly affected CDT levels. The distributions for the CDT and GGT levels according to mean daily alcohol consumption are presented in Table 3 . Individuals who had a mean daily alcohol intake of more than 60 g/day showed significantly higher CDT levels than those who consumed less than 60 g/day (P=0.034). CDT values were lower in groups who had a longer duration of alcohol abstinence, although this finding was statistically insignificant (Table 4) . Table 2 . Distribution of %CDT using capillary electrophoresis and GGT in healthy abstinent individuals and abstinent patients with liver disease
Abbreviations: CDT, carbohydrate-deficient transferrin; GGT, g -glutamyl transpeptidase. 
Sensitivities and specificities of CDT using capillary EP
Receive operating characteristic (ROC) curves and sensitivities and specificities of CDT measurement using capillary EP at different cut-off limits for each mean alcohol consumption value are shown in Table 5 and Fig.   3 . The area under the ROC curves (AUC) was larger for mean alcohol consumption detection, which was greater than or equal to 40 g/day, than smaller volumes. The sensitivities and specificities were best at the cut-off limit of 0.75-0.95%, depending on the different mean alcohol doses.
DISCUSSION
Methods to determine CDT levels, such as isoelectric focusing, anion-exchange chromatography, and HPLC, are complex, time-consuming, and laborious [1, 8, 14] .
Capillary EP for CDT testing is fully automated, timesaving, and adaptable for use with all of the transferrin glycoforms. In the present study, total precision for capillary EP (6.6% and 4.5% at the low and high levels of CDT, respectively) was better than that of other methods [14] [15] [16] . The results were comparable to those of other studies that used capillary EP [11, 14, 17, 18] . CDT 
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These variants can be detected using capillary EP, but the measured CDT levels would be inaccurate. The rate of genetic variations is low in Caucasians (<1%) but is reported to be high in African-Americans, Black Africans, and natives of South America [14, 19] . In our study, 5 of 121 individuals (4.1%) had a genetic variant of the Tf isoforms (BC or CD variant).
Although CDT tests are known to have the highest specificity for alcohol abuse, as compared to other laboratory tests such as GGT, the reported sensitivities and specificities of CDT ranged broadly [18, 20] . Sensitivities were reported to vary from <20% to 100%. Specificities varied from 75% to 100%. This variability was due to differences in the populations, CDT methods, CDT cut-off points, and definitions of alcohol abuse. The sensitivity and specificity were higher in studies that focused on completely contrasting groups, such as alcohol abstainers and heavy alcohol drinkers, but were much lower in clinical settings that included many patients who had liver disease and were moderate alcohol drinkers [18, 20, 21] .
In the present study, we evaluated the performance of CDT testing using capillary EP in a population of patients who were alcoholic, had non-alcoholic liver disease, or [19] . However, in patients who have liver disease, the CDT levels increased to a lesser extent than GGT levels. In addition, the positive rate of CDT, according to the cut-off value of 1.3%, was very low in patients who had liver disease in contrast to GGT. Thus, CDT can be more useful than GGT for monitoring alcohol consumption in patients who have liver disease. Using a ROC curve, the appropriate cut-off and best sensitivities and specificities can be estimated. The AUC was larger for the detection of mean alcohol consumptions of 40 g/day or more than 60 or 120 g/day.
The sensitivities and specificities in the present study were comparable to studies which included moderate drinkers [3, 21] , but were lower than studies that included extreme groups [18] . The sensitivity and specificity were best at the cut-off limit of 0.75-0.95%. This was lower than the suggested cut-off limit of 1.3%. other biomarkers has been recommended [18, 20] .
In summary, the capillary EP method for measurement of CDT levels showed good performance and had several advantages. CDT can be a more useful marker than GGT for monitoring abstinence, particularly in patients who have liver disease. Further studies are required to elucidate pre-analytic variables, determine cut-off values under various conditions, and standardize the assays before this test can be routinely used.
